Evidence map›Paper›PMID 42170346›Full record

ArticleChemical science2026

A machine learning-based workflow for transaminase selection.

Alexander J Rago, Priyanka Raghavan, Lisandra Santiago-Capeles, Ruijie Zhang, Ying Wang, Connor W Coley

Abstract read
In one paragraph

Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexander J RagoSmall Molecule Chemistry Technologies, AbbVie, Inc. 1 N Waukegan Rd North Chicago IL 60064 USA alex.rago@abbvie.com wang.ying@abbvie.com.ORCID https://orcid.org/0000-0002-9621-1974
Priyanka RaghavanDepartment of Chemical Engineering, Massachusetts Institute of Technology 77 Massachusetts Ave Cambridge Massachusetts 02139 USA ccoley@mit.edu.ORCID https://orcid.org/0009-0002-5949-4570
Lisandra Santiago-CapelesSmall Molecule Chemistry Technologies, AbbVie, Inc. 1 N Waukegan Rd North Chicago IL 60064 USA alex.rago@abbvie.com wang.ying@abbvie.com.
Ruijie ZhangSmall Molecule Chemistry Technologies, AbbVie, Inc. 1 N Waukegan Rd North Chicago IL 60064 USA alex.rago@abbvie.com wang.ying@abbvie.com.
Ying WangSmall Molecule Chemistry Technologies, AbbVie, Inc. 1 N Waukegan Rd North Chicago IL 60064 USA alex.rago@abbvie.com wang.ying@abbvie.com.ORCID https://orcid.org/0000-0001-9516-3483
Connor W ColeyDepartment of Chemical Engineering, Massachusetts Institute of Technology 77 Massachusetts Ave Cambridge Massachusetts 02139 USA ccoley@mit.edu.ORCID https://orcid.org/0000-0002-8271-8723

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transaminases can be strategically used in medicinal chemistry for the synthesis of chiral amine building blocks in a straightforward manner that alleviates the need for chiral preparative separations. However, selection of the commercial transaminase variant to use for a given substrate can be a challenging task without prior knowledge or experience with their reactivity. Herein, we describe the construction of a dataset of 336 transaminase reactions using high-throughput experimentation (HTE) and the subsequent development of machine learning (ML) models to predict enzyme activities and selectivities. Our results demonstrate the ability of these models to predict substrate conversions and top-

Identifiers

PMID42170346
PMCPMC13187754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.